$3.18+0.11 (+3.58%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Ardelyx (ARDX) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
1 figure withheld by our checks. Each blank figure names its reason.
Business engineGrowing fast: revenue compounds ~152.0%/yr (FY21→FY25), net margin −15.1%. Worth your attention in FY25: Share count (+131.3%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲22.1%
407.3
FY21→FY25CAGR +152.0%/yr
Net income ($M)▼57.4%
−61.6
FY21→FY25CAGR —
Free cash flow ($M)▲4.0%
−44.0
FY21→FY25CAGR —
Diluted EPS▼52.9%
−0.26
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+131.3%
104.2mn → 241.0mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex
$1.5M
+47.6% YoY in FY25 · 0.4% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-15¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 90.1% → 90.3%. Net margin -15.1% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 468,220.0 | 407,320.0 | 333,615.0 | 124,456.0 | 52,158.0 | 10,097.0 | ▲22.1% | +152.0% |
Cost of revenue | 25,958.0 | 39,537.0 | 50,556.0 | 17,795.0 | 4,117.0 | 1,000.0 | ▼21.8% | +150.8% |
Gross profit | 442,262.0 | 367,783.0 | 283,059.0 | 106,661.0 | 48,041.0 | 9,097.0 | ▲29.9% | +152.2% |
Research & development | 94,346.0 | 71,527.0 | 52,317.0 | 35,536.0 | 35,201.0 | 91,140.0 | ▲36.7% | −5.9% |
Selling, general & admin | 384,012.0 | 337,233.0 | 258,692.0 | 134,401.0 | 76,599.0 | 72,303.0 | ▲30.4% | +47.0% |
Total operating expenses | 478,358.0 | 408,760.0 | 311,009.0 | 169,937.0 | 111,800.0 | 163,443.0 | ▲31.4% | +25.8% |
Operating incomefeeds ROC rank | −36,096.0 | −40,977.0 | −27,950.0 | −63,276.0 | −63,759.0 | −154,346.0 | ▼46.6% | — |
Other income, net | −19,159.0 | −19,653.0 | −10,920.0 | −2,244.0 | −3,440.0 | −3,815.0 | — | — |
Pretax income | −55,255.0 | −60,630.0 | −38,870.0 | −65,520.0 | −67,199.0 | −158,161.0 | ▼56.0% | — |
Income tax | 215.0 | 969.0 | 266.0 | 547.0 | 8.0 | 4.0 | ▲264.3% | +294.5% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −55,470.0 | −61,599.0 | −39,136.0 | −66,067.0 | −67,207.0 | −158,165.0 | ▼57.4% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.23 | −0.26 | −0.17 | −0.30 | −0.42 | −1.52 | ▼52.9% | — |
Diluted shares (mn) | 250.01 | 241.03 | 235.23 | 219.33 | 158.69 | 104.21 | ▲2.5% | +23.3% |
| Margins | ||||||||
Gross margin92nd pct in Healthcare | 94.5% | 90.3% | 84.8% | 85.7% | 92.1% | 90.1% | ▲5.4pp | +0.2pp |
Operating margin | −7.7% | −10.1% | −8.4% | −50.8% | −122.2% | −1528.6% | ▼1.7pp | +1518.6pp |
Net margin26th pct in Healthcare | −11.8% | −15.1% | −11.7% | −53.1% | −128.9% | −1566.5% | ▼3.4pp | +1551.3pp |
† TTM = trailing four quarters through 2026-09-30.
5 more years of statements and CSV export are on Premium, and 8 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-19 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Ardelyx's revenue last fiscal year?
Ardelyx reported revenue of $407.3M in fiscal 2025, up 22.1% from fiscal 2024.
What was Ardelyx's net income?
Ardelyx reported net income of −$61.6M in fiscal 2025, a net margin of −15.1%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

